FEATURED COMPANIES
- Achelios Therapeutics
- Bayer HealthCare
- DURECT
- Hospira
- Novartis
- Sanofi
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
About the Analgesics Market
Analgesics are among the most commonly prescribed drugs for pain, especially that from fractures, ankle sprains, and other injuries. These are designed particularly for pain relief. Opioids, NSAIDs, and local anesthetics are the major analgesics used to treat pain. The long term use of analgesics has been linked to gastrointestinal problems. Pain is treated with analgesics, also called as pain killers, many of which are accessible without a prescription, including acetaminophen, aspirin, or ibuprofen. These medicines are termed as non-prescription or OTC analgesics and can be used either alone for mild pain or in combination with other medicines for severe pain.
The analysts forecast the global analgesics market to grow at a CAGR of 4.28% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global analgesics market for 2016-2020. To calculate the market size, the analyst considers the revenue generated from the total consumption of analgesics globally. The report does not include revenue generated from the aftermarket service of the product.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
The report, Global Analgesics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- Pfizer
- Bayer HealthCare
- Sanofi
- Endo
- Johnson & Johnson
- Purdue Pharma
Other prominent vendors
- Achelios Therapeutics
- Alder BioPharmaceuticals
- Allergan
- Amgen
- AstraZeneca
- Baxter
- Boehringer Ingelheim
- Bristol Myers Squibb
- CoLucid Pharmaceuticals
- Daiichi Sankyo
- Dr. Reddy's Laboratories
- DURECT
- El Lilly & Company
- F. Hoffmann La Roche
- GlaxoSmithKline
- GW Pharmaceuticals
- Hospira
- Immune Pharmaceuticals
- Innovative Med Concepts
- Merck
- NeurAxon
- Novartis
- OptiNose
- Pain Therapeutics
- RedHill
- Sorrento Therapeutics
- Suda
- Taro Pharmaceuticals Industries
- Teva Pharmaceuticals Industries
- Tonix Pharmaceuticals
- Trigemina
- UCB
- Valeant Pharmaceuticals International
- WEX Pharmaceuticals
- Zynerba Pharmaceuticals
Market drivers
- Increase in self-medication
Market challenges
- Preference for alternative therapies
Market trends
- Accelerated use of online resources
Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Analgesics are among the most commonly prescribed drugs for pain, especially that from fractures, ankle sprains, and other injuries. These are designed particularly for pain relief. Opioids, NSAIDs, and local anesthetics are the major analgesics used to treat pain. The long term use of analgesics has been linked to gastrointestinal problems. Pain is treated with analgesics, also called as pain killers, many of which are accessible without a prescription, including acetaminophen, aspirin, or ibuprofen. These medicines are termed as non-prescription or OTC analgesics and can be used either alone for mild pain or in combination with other medicines for severe pain.
The analysts forecast the global analgesics market to grow at a CAGR of 4.28% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global analgesics market for 2016-2020. To calculate the market size, the analyst considers the revenue generated from the total consumption of analgesics globally. The report does not include revenue generated from the aftermarket service of the product.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
The report, Global Analgesics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- Pfizer
- Bayer HealthCare
- Sanofi
- Endo
- Johnson & Johnson
- Purdue Pharma
Other prominent vendors
- Achelios Therapeutics
- Alder BioPharmaceuticals
- Allergan
- Amgen
- AstraZeneca
- Baxter
- Boehringer Ingelheim
- Bristol Myers Squibb
- CoLucid Pharmaceuticals
- Daiichi Sankyo
- Dr. Reddy's Laboratories
- DURECT
- El Lilly & Company
- F. Hoffmann La Roche
- GlaxoSmithKline
- GW Pharmaceuticals
- Hospira
- Immune Pharmaceuticals
- Innovative Med Concepts
- Merck
- NeurAxon
- Novartis
- OptiNose
- Pain Therapeutics
- RedHill
- Sorrento Therapeutics
- Suda
- Taro Pharmaceuticals Industries
- Teva Pharmaceuticals Industries
- Tonix Pharmaceuticals
- Trigemina
- UCB
- Valeant Pharmaceuticals International
- WEX Pharmaceuticals
- Zynerba Pharmaceuticals
Market drivers
- Increase in self-medication
Market challenges
- Preference for alternative therapies
Market trends
- Accelerated use of online resources
Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Achelios Therapeutics
- Bayer HealthCare
- DURECT
- Hospira
- Novartis
- Sanofi
PART 01: Executive summary
PART 15: Market challenges
PART 17: Market trends
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Pain assessment
Exhibit 03: Types of pain scales
Exhibit 04: Treatment options for pain
Exhibit 05: Commonly used non-opioids for pain
Exhibit 06: Commonly used adjuvant medicines for pain
Exhibit 07: Treatment algorithm for pain
Exhibit 08: Pipeline portfolio: Major analgesic candidates under development for pain
Exhibit 09: Global analgesics market 2015-2020 ($ billions)
Exhibit 10: Five forces analysis
Exhibit 11: Global analgesics market by drug class
Exhibit 12: Segmentation of global analgesics market by drug class 2015
Exhibit 13: Global analgesics market segmentation by drug class 2015-2020 ($ billions)
Exhibit 14: Global analgesics market segmentation by drug class 2015-2020
Exhibit 15: Global analgesics market: YoY revenue and growth based on drug class 2015-2020 ($ billions)
Exhibit 16: Global opioids market 2015-2020 ($ billions)
Exhibit 17: Global NSAIDs market 2015-2020 ($ billions)
Exhibit 18: Global analgesics segmentation by type
Exhibit 19: Global analgesics segmentation by type 2015
Exhibit 20: Global analgesics market segmentation by type 2015-2020 ($ billions)
Exhibit 21: Global analgesics market segmentation by type 2015-2020
Exhibit 22: Global analgesics market: YoY revenue and growth based on type 2015-2020 ($ billions)
Exhibit 23: Global prescription analgesics market 2015-2020 ($ billions)
Exhibit 24: Global OTC analgesics market 2015-2020 ($ billions)
Exhibit 25: Global analgesics market segmentation by application
Exhibit 26: Global internal analgesics market 2015-2020 ($ billions)
Exhibit 27: Global external analgesics market 2015-2020 ($ billions)
Exhibit 28: Global analgesics market segmentation by application 2015-2020 ($ billions)
Exhibit 29: Global analgesics market segmentation by application 2015-2020
Exhibit 30: Global analgesics market: YoY revenue and growth based on application 2015-2020 ($ billions)
Exhibit 31: Global analgesics market segmentation by type
Exhibit 32: Global analgesics market segmentation by type 2015
Exhibit 33: Global analgesics market segmentation by ROA
Exhibit 34: Global analgesics market segmentation by ROA 2015
Exhibit 35: Global analgesics market by geography 2015
Exhibit 36: Global analgesics market revenue by geography 2015-2020 ($ billions)
Exhibit 37: Global analgesics market revenue by geography 2015-2020
Exhibit 38: Global analgesics market: YoY revenue and growth based on geography 2015-2020 ($ billions)
Exhibit 39: Analgesics market in Americas 2015-2020 ($ billions)
Exhibit 40: Analgesics market in EMEA 2015-2020 ($ billions)
Exhibit 41: Analgesics market in APAC 2015-2020 ($ billions)
Exhibit 42: Population aged 60 years and over: World, developed, and developing regions (millions)
Exhibit 43: Expected growth of older population in US 2010-2050
Exhibit 44: Impact of drivers
Exhibit 45: Alternative therapies for pain
Exhibit 46: Use of CAM therapies among individuals in US
Exhibit 47: Impact of drivers and challenges
Exhibit 48: Global Internet penetration rate 2015
Exhibit 49: Market share analysis 2015
Exhibit 50: Revenue share of major companies for global analgesics market 2015
Exhibit 51: Revenues from the sales of top five analgesics 2013-2015 ($ millions)
Exhibit 52: Pfizer: YoY revenue and growth rate of Lyrica 2013-2015 ($ billions)
Exhibit 53: Pfizer: YoY revenue and growth rate of Celebrex 2013-2015 ($ billions)
Exhibit 54: Pfizer: YoY revenue and growth rate of Relpax 2013-2015 ($ millions)
Exhibit 55: Pfizer: Key takeaways
Exhibit 56: Bayer HealthCare: YoY revenue and growth rate of Aspirin 2013-2015 ($ millions)
Exhibit 57: Bayer HealthCare: YoY revenue and growth rate of Aleve 2013-2015 ($ millions)
Exhibit 58: Bayer HealthCare: Key takeaways
Exhibit 59: Sanofi: YoY revenue and growth rate of Doliprane 2013-2015 ($ millions)
Exhibit 60: Sanofi: YoY revenue and growth rate of Dorflex 2013-2015 ($ millions)
Exhibit 61: Sanofi: YoY revenue and growth rate of Synvisc/Synvisc One 2013-2015 ($ millions)
Exhibit 62: Sanofi: YoY revenue and growth rate of No Spa 2013-2015 ($ millions)
Exhibit 63: Sanofi: Key takeaways
Exhibit 64: Endo International: YoY revenue and growth rate of Opana ER 2013-2015 ($ millions)
Exhibit 65: Endo International: YoY revenue and growth rate of Voltaren 2013-2015 ($ millions)
Exhibit 66: Endo International: YoY revenue and growth rate of Lidoderm 2013-2015 ($ millions)
Exhibit 67: Endo International: YoY revenue and growth rate of Percocet 2013-2015 ($ millions)
Exhibit 68: Endo International: Key takeaways
Exhibit 69: Johnson & Johnson: Key takeaways
Exhibit 70: Purdue Pharma: Key takeaways
- Highlights
- Market overview
- Assumptions
- Top-vendor offerings
- Research methodology
- Economic indicators
- Key market highlights
- Pain: Overview
- Information on pipeline candidates
- Market overview
- Market size and forecast
- Five forces analysis
- Opioids
- NSAIDs
- Other
- Global opioids market
- Global NSAIDs Market
- Prescription analgesics
- OTC analgesics
- Global internal analgesics market
- Global external analgesics market
- Musculoskeletal pain
- Surgical and trauma pain
- Cancer pain
- Neuropathic pain
- Migraine
- Obstetrical pain
- Pain due to burns
- Dental/facial pain
- Pediatric pain
- Oral
- Parenteral
- Topical
- Transdermal
- Rectal
- Analgesics market in Americas
- Analgesics market in EMEA
- Analgesics market in APAC
- Growing geriatric population
- Increase in self-medication
- Promising pipeline
- Favorable regulatory scenario
PART 15: Market challenges
- Generic competition
- Preference for alternative therapies
- Counterfeit pharmaceuticals
PART 17: Market trends
- Accelerated use of online resources
- Increase in R&D
- Off-label drugs use
- Strategic alliances
- Competitive scenario
- Market share analysis 2015
- Pfizer
- Bayer Healthcare
- Sanofi
- Endo International
- Johnson & Johnson
- Purdue Pharma
- Other prominent vendors
- List of abbreviations
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Pain assessment
Exhibit 03: Types of pain scales
Exhibit 04: Treatment options for pain
Exhibit 05: Commonly used non-opioids for pain
Exhibit 06: Commonly used adjuvant medicines for pain
Exhibit 07: Treatment algorithm for pain
Exhibit 08: Pipeline portfolio: Major analgesic candidates under development for pain
Exhibit 09: Global analgesics market 2015-2020 ($ billions)
Exhibit 10: Five forces analysis
Exhibit 11: Global analgesics market by drug class
Exhibit 12: Segmentation of global analgesics market by drug class 2015
Exhibit 13: Global analgesics market segmentation by drug class 2015-2020 ($ billions)
Exhibit 14: Global analgesics market segmentation by drug class 2015-2020
Exhibit 15: Global analgesics market: YoY revenue and growth based on drug class 2015-2020 ($ billions)
Exhibit 16: Global opioids market 2015-2020 ($ billions)
Exhibit 17: Global NSAIDs market 2015-2020 ($ billions)
Exhibit 18: Global analgesics segmentation by type
Exhibit 19: Global analgesics segmentation by type 2015
Exhibit 20: Global analgesics market segmentation by type 2015-2020 ($ billions)
Exhibit 21: Global analgesics market segmentation by type 2015-2020
Exhibit 22: Global analgesics market: YoY revenue and growth based on type 2015-2020 ($ billions)
Exhibit 23: Global prescription analgesics market 2015-2020 ($ billions)
Exhibit 24: Global OTC analgesics market 2015-2020 ($ billions)
Exhibit 25: Global analgesics market segmentation by application
Exhibit 26: Global internal analgesics market 2015-2020 ($ billions)
Exhibit 27: Global external analgesics market 2015-2020 ($ billions)
Exhibit 28: Global analgesics market segmentation by application 2015-2020 ($ billions)
Exhibit 29: Global analgesics market segmentation by application 2015-2020
Exhibit 30: Global analgesics market: YoY revenue and growth based on application 2015-2020 ($ billions)
Exhibit 31: Global analgesics market segmentation by type
Exhibit 32: Global analgesics market segmentation by type 2015
Exhibit 33: Global analgesics market segmentation by ROA
Exhibit 34: Global analgesics market segmentation by ROA 2015
Exhibit 35: Global analgesics market by geography 2015
Exhibit 36: Global analgesics market revenue by geography 2015-2020 ($ billions)
Exhibit 37: Global analgesics market revenue by geography 2015-2020
Exhibit 38: Global analgesics market: YoY revenue and growth based on geography 2015-2020 ($ billions)
Exhibit 39: Analgesics market in Americas 2015-2020 ($ billions)
Exhibit 40: Analgesics market in EMEA 2015-2020 ($ billions)
Exhibit 41: Analgesics market in APAC 2015-2020 ($ billions)
Exhibit 42: Population aged 60 years and over: World, developed, and developing regions (millions)
Exhibit 43: Expected growth of older population in US 2010-2050
Exhibit 44: Impact of drivers
Exhibit 45: Alternative therapies for pain
Exhibit 46: Use of CAM therapies among individuals in US
Exhibit 47: Impact of drivers and challenges
Exhibit 48: Global Internet penetration rate 2015
Exhibit 49: Market share analysis 2015
Exhibit 50: Revenue share of major companies for global analgesics market 2015
Exhibit 51: Revenues from the sales of top five analgesics 2013-2015 ($ millions)
Exhibit 52: Pfizer: YoY revenue and growth rate of Lyrica 2013-2015 ($ billions)
Exhibit 53: Pfizer: YoY revenue and growth rate of Celebrex 2013-2015 ($ billions)
Exhibit 54: Pfizer: YoY revenue and growth rate of Relpax 2013-2015 ($ millions)
Exhibit 55: Pfizer: Key takeaways
Exhibit 56: Bayer HealthCare: YoY revenue and growth rate of Aspirin 2013-2015 ($ millions)
Exhibit 57: Bayer HealthCare: YoY revenue and growth rate of Aleve 2013-2015 ($ millions)
Exhibit 58: Bayer HealthCare: Key takeaways
Exhibit 59: Sanofi: YoY revenue and growth rate of Doliprane 2013-2015 ($ millions)
Exhibit 60: Sanofi: YoY revenue and growth rate of Dorflex 2013-2015 ($ millions)
Exhibit 61: Sanofi: YoY revenue and growth rate of Synvisc/Synvisc One 2013-2015 ($ millions)
Exhibit 62: Sanofi: YoY revenue and growth rate of No Spa 2013-2015 ($ millions)
Exhibit 63: Sanofi: Key takeaways
Exhibit 64: Endo International: YoY revenue and growth rate of Opana ER 2013-2015 ($ millions)
Exhibit 65: Endo International: YoY revenue and growth rate of Voltaren 2013-2015 ($ millions)
Exhibit 66: Endo International: YoY revenue and growth rate of Lidoderm 2013-2015 ($ millions)
Exhibit 67: Endo International: YoY revenue and growth rate of Percocet 2013-2015 ($ millions)
Exhibit 68: Endo International: Key takeaways
Exhibit 69: Johnson & Johnson: Key takeaways
Exhibit 70: Purdue Pharma: Key takeaways
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Achelios Therapeutics
- Bayer HealthCare
- DURECT
- Hospira
- Novartis
- Sanofi
New Report Released: - Global Analgesics Market 2016-2020
The author of the report recognizes the following companies as the key players in the global analgesics market: Pfizer, Bayer HealthCare, Sanofi, Endo International, Johnson & Johnson, and Purdue Pharma.
Other Prominent Vendors in the market are: Achelios Therapeutics, Alder BioPharmaceuticals, Allergan, Amgen, AstraZeneca, Baxter, Boehringer Ingelheim, Bristol Myers Squibb, CoLucid Pharmaceuticals, Daiichi Sankyo, Dr. Reddy's Laboratories, DURECT, El Lilly & Company, F. Hoffmann La Roche, GlaxoSmithKline, GW Pharmaceuticals, Hospira, Immune Pharmaceuticals, Innovative Med Concepts, Merck, NeurAxon, Novartis, OptiNose, Pain Therapeutics, RedHill, Sorrento Therapeutics, Suda, Taro Pharmaceuticals Industries, Teva Pharmaceuticals Industries, Tonix Pharmaceuticals, Trigemina, UCB, Valeant Pharmaceuticals International, WEX Pharmaceuticals, and Zynerba Pharmaceuticals.
Commenting on the report, an analyst from the research team said: “A key trend which is boosting market growth is the accelerated use of online resources. Several manufacturers and retailers are shifting their marketing strategy to the online platform to achieve high-volume sales and offer convenience and comfort for end-users. For instance, websites such as vitacost.com, healthkart.com, rxexpress.co.uk, and vivavitamins.com offer pain tablets, caplets, gels, creams, and ointments. These sites provide options such as live chat to provide instant support to individuals who face difficulties when purchasing pain medication.”
According to the report, a key growth driver is the rapid industrialization in China. Changes in government policies of countries are increasing the preference for OTC drugs over prescription drugs. These drugs do not require a written prescription from healthcare professionals and can be purchased directly from pharmacy stores. This is a major factor that promotes the increased use of these products and a rise in the practice of self-medication. For instance, people with pain conditions use analgesics such as acetaminophen, aspirin, ibuprofen, and diclofenac.
Further, the report states that a major factor that could hamper market growth is the growing preference for alternative therapies. Many analgesics do not show the required long-term efficacy, which leads to patients opting for non-pharmacologic treatments for pain relief. Also, patients sometimes become allergic or experience severe side-effects from drugs or deterioration of a pre-existing disease with the use of these medications.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
The author of the report recognizes the following companies as the key players in the global analgesics market: Pfizer, Bayer HealthCare, Sanofi, Endo International, Johnson & Johnson, and Purdue Pharma.
Other Prominent Vendors in the market are: Achelios Therapeutics, Alder BioPharmaceuticals, Allergan, Amgen, AstraZeneca, Baxter, Boehringer Ingelheim, Bristol Myers Squibb, CoLucid Pharmaceuticals, Daiichi Sankyo, Dr. Reddy's Laboratories, DURECT, El Lilly & Company, F. Hoffmann La Roche, GlaxoSmithKline, GW Pharmaceuticals, Hospira, Immune Pharmaceuticals, Innovative Med Concepts, Merck, NeurAxon, Novartis, OptiNose, Pain Therapeutics, RedHill, Sorrento Therapeutics, Suda, Taro Pharmaceuticals Industries, Teva Pharmaceuticals Industries, Tonix Pharmaceuticals, Trigemina, UCB, Valeant Pharmaceuticals International, WEX Pharmaceuticals, and Zynerba Pharmaceuticals.
Commenting on the report, an analyst from the research team said: “A key trend which is boosting market growth is the accelerated use of online resources. Several manufacturers and retailers are shifting their marketing strategy to the online platform to achieve high-volume sales and offer convenience and comfort for end-users. For instance, websites such as vitacost.com, healthkart.com, rxexpress.co.uk, and vivavitamins.com offer pain tablets, caplets, gels, creams, and ointments. These sites provide options such as live chat to provide instant support to individuals who face difficulties when purchasing pain medication.”
According to the report, a key growth driver is the rapid industrialization in China. Changes in government policies of countries are increasing the preference for OTC drugs over prescription drugs. These drugs do not require a written prescription from healthcare professionals and can be purchased directly from pharmacy stores. This is a major factor that promotes the increased use of these products and a rise in the practice of self-medication. For instance, people with pain conditions use analgesics such as acetaminophen, aspirin, ibuprofen, and diclofenac.
Further, the report states that a major factor that could hamper market growth is the growing preference for alternative therapies. Many analgesics do not show the required long-term efficacy, which leads to patients opting for non-pharmacologic treatments for pain relief. Also, patients sometimes become allergic or experience severe side-effects from drugs or deterioration of a pre-existing disease with the use of these medications.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
- Pfizer
- Bayer HealthCare
- Sanofi
- Endo International
- Johnson & Johnson
- Purdue Pharma
- Achelios Therapeutics
- Alder BioPharmaceuticals
- Allergan
- Amgen
- AstraZeneca
- Baxter
- Boehringer Ingelheim
- Bristol Myers Squibb
- CoLucid Pharmaceuticals
- Daiichi Sankyo
- Dr. Reddy's Laboratories
- DURECT
- El Lilly & Company
- F. Hoffmann La Roche
- GlaxoSmithKline
- GW Pharmaceuticals
- Hospira
- Immune Pharmaceuticals
- Innovative Med Concepts
- Merck
- NeurAxon
- Novartis
- OptiNose
- Pain Therapeutics
- RedHill
- Sorrento Therapeutics
- Suda
- Taro Pharmaceuticals Industries
- Teva Pharmaceuticals Industries
- Tonix Pharmaceuticals
- Trigemina
- UCB
- Valeant Pharmaceuticals International
- WEX Pharmaceuticals
- Zynerba Pharmaceuticals.
- Bayer HealthCare
- Sanofi
- Endo International
- Johnson & Johnson
- Purdue Pharma
- Achelios Therapeutics
- Alder BioPharmaceuticals
- Allergan
- Amgen
- AstraZeneca
- Baxter
- Boehringer Ingelheim
- Bristol Myers Squibb
- CoLucid Pharmaceuticals
- Daiichi Sankyo
- Dr. Reddy's Laboratories
- DURECT
- El Lilly & Company
- F. Hoffmann La Roche
- GlaxoSmithKline
- GW Pharmaceuticals
- Hospira
- Immune Pharmaceuticals
- Innovative Med Concepts
- Merck
- NeurAxon
- Novartis
- OptiNose
- Pain Therapeutics
- RedHill
- Sorrento Therapeutics
- Suda
- Taro Pharmaceuticals Industries
- Teva Pharmaceuticals Industries
- Tonix Pharmaceuticals
- Trigemina
- UCB
- Valeant Pharmaceuticals International
- WEX Pharmaceuticals
- Zynerba Pharmaceuticals.
Note: Product cover images may vary from those shown
LOADING...
